Quantcast
Last updated on April 18, 2014 at 8:37 EDT

Latest TAT Stories

2012-03-08 15:03:00

Events include live music, a movie premiere, custom gear giveaways, and robust online presence WASHINGTON, March 8, 2012 /PRNewswire-USNewswire/ -- truth, the nation's largest youth smoking prevention campaign, is teaming up with longtime partner and top youth brand Vans to bring its iconic orange truth truck, truth tour riders, and important life-saving messages to Austin, TX during South by Southwest (SXSW). Over nine days, an on-site truth crew will meet with festivalgoers, give...

2012-01-09 06:00:00

RICHMOND, Calif., Jan. 9, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the initiation of two new Phase 2 clinical studies (SB-728-1101 and SB-728-902, Cohort 5) in its program to develop a "functional cure" for HIV/AIDS. Sangamo's ZFP Therapeutic(®)( )approach (SB-728-T) generates T-cells that are resistant to HIV infection using its zinc finger nuclease (ZFN) technology to permanently disrupt the DNA sequence encoding CCR5, a co-receptor used by HIV to...

2011-12-22 06:58:01

Discovery offers new research avenues for fighting this global epidemic Gladstone Institutes scientist Nevan Krogan, PhD, today is announcing research that identifies how HIV–the virus that causes AIDS–hijacks the body's own defenses to promote infection. This discovery could one day help curb the spread of the HIV/AIDS pandemic. Dr. Krogan conducted this research in his laboratory at the University of California, San Francisco (UCSF)–a leading medical school with...

2011-12-22 06:56:25

Hundreds of connections between viral and human proteins identified in UCSF-led study -- work that may reveal new drug targets In perhaps the most comprehensive survey of the inner workings of HIV, an international team of scientists led by researchers at the University of California, San Francisco has mapped every apparent physical interaction the virus makes with components of the human cells it infects–work that may reveal new ways to design future HIV/AIDS drugs. Explored this...

2011-09-08 06:00:00

RICHMOND, Calif., Sept. 8, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that data from all dosing cohorts of its Phase 1 study (SB-728-902) to evaluate SB-728-T for HIV/AIDS as well as preliminary data from the Phase 1 clinical study of the same drug, ongoing at the University of Pennsylvania, will be presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The meeting will be held September 17-20, 2011 in Chicago....

2011-02-28 07:30:00

RICHMOND, Calif., Feb. 28, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of positive preliminary clinical data from its Phase 1 trial (SB-728-902). The trial is being conducted in immunologic non-responders, HIV-infected subjects who are currently on highly active antiretroviral therapy (HAART) and have undetectable levels of virus but suboptimal CD4+ T-cell counts. The study is designed to evaluate safety and clinical outcomes of...

2011-02-03 01:39:00

GEDERA, Israel, February 3, 2011 /PRNewswire-FirstCall/ -- TAT Technologies Ltd. (Nasdaq:TATT), a leading provider of services and products to the commercial and military aerospace and ground defense industries, today announced that its wholly-owned subsidiary, Piedmont Aviation Component Services ("Piedmont"), has signed a five year APU (Auxiliary Power Unit - a small gas turbine engine) maintenance Agreement with Austrian Airlines ("Austrian") covering Austrian Boeing 767 fleet...

2010-11-04 18:08:49

Variations in protein structure impact effectiveness of immune response Tiny variants in a protein that alerts the immune system to the presence of infection may underlie the rare ability of some individuals to control HIV infection without the need for medications. In a report that will appear in Science and is receiving early online release, an international research team led by investigators from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard and from the...

2010-07-20 05:40:00

GEDERA, Israel, July 20, 2010 /PRNewswire-FirstCall/ -- TAT Technologies Ltd. (Nasdaq: TATT - News), a leading provider of services and products to the commercial and military aerospace and ground defense industries, today announced that its wholly-owned subsidiary, Piedmont Aviation Component Services ("Piedmont"), has expanded its APU Authorized Repair Center Agreement with Honeywell International Inc. ("Honeywell") to add another type of APU ( Auxiliary Power Unit - a small gas turbine...

2010-07-06 06:00:00

RICHMOND, Calif., July 6 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the publication of data demonstrating the preclinical efficacy of a human stem cell therapy for human immunodeficiency virus (HIV) based on its proprietary zinc finger DNA-binding protein nuclease (ZFN) technology. The ZFN approach enables the permanent disruption of the CCR5 gene, which encodes an important receptor for HIV infection, in all the cell types comprising the immune system...